Journal profile · ONCOLOGY

European Journal of Breast Health

ISSN 2587-0831 · Galenos Publishing House · Türkiye

European Journal of Breast Health: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.1 (journal website); fully open access; APC about USD 50; review about 24 weeks (community reports); 79 articles in 2025; indexed in ESCI and Scopus.

Impact factor2.1From the journal's website, latest value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review timeabout 24 weeksCommunity average
APCUSD 50Fully open access
Acceptance—No reports yet
Articles per year792025 · OpenAlex count

Scope

Aims, scope and focus

European Journal of Breast Health is published by Galenos Publishing House and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Breast Lesions and Carcinomas and Breast Implant and Reconstruction, together about 45.6% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)

European Journal of Breast Health is an open access, scientific, double-blind peer-reviewed journal in the field of breast diseases. No fee is charged from the authors during the submission, evaluation and publication process. It is the official publication of Turkish Federation of Breast Diseases Societies, and is published quarterly in English.

From the journal's Aims & Scope

Research area (LetPub): ONCOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology19.4%
  2. Breast Lesions and CarcinomasMedicine17.5%
  3. Breast Implant and ReconstructionMedicine8.7%
  4. Global Cancer Incidence and ScreeningMedicine7.4%
  5. Male Breast Health StudiesMedicine4.9%
  6. Cancer Risks and FactorsMedicine4.6%
  7. Cancer and Skin LesionsMedicine3.5%
  8. BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology3.2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
2.1Publisher website ·
5-year impact factor (publisher)
2Publisher website ·
CiteScore 2026-06
3LetPub ·
CiteScore (publisher) 2024
3Publisher website ·
SJR 2026-06
0.52LetPub ·
SNIP 2026-06
0.78LetPub ·
h-index
31OpenAlex ·
i10-index
159OpenAlex ·
2-year mean citedness
1.75OpenAlex ·
Self-citation rate
4.8%LetPub ·
Share of gold OA articles
99.28%LetPub ·

Volume

Articles per year
52LetPub ·

Articles by year OpenAlex count · 533 in total · the current year is incomplete

YearArticlesOpen accessCitations
202655559
20257979116
20243535171
20234747271
20224848316
20216868795

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 24 weeksLetPub ·
Submission to publication (journal-reported)
about 24 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 50NoCC BY-NC-ND
LetPubUSD 50No—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Galenos Publishing House
Country or region
Türkiye
Language
English
ISSN
2587-0831
Official links

FAQ

Frequently asked questions about European Journal of Breast Health

What CAS zone is European Journal of Breast Health in?

In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Breast Health is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of European Journal of Breast Health?

The journal's website gives an impact factor of 2.1; this is the journal's own figure, as LetPub lists none for it; CiteScore 3, h-index 31.

How long does peer review take at European Journal of Breast Health?

Authors report an average review time of about 24 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index European Journal of Breast Health?

According to LetPub and DOAJ records, European Journal of Breast Health is indexed in ESCI, Scopus and DOAJ.

Is European Journal of Breast Health open access, and what is the APC?

European Journal of Breast Health is a fully open-access journal. APC about USD 50.

Sources and updates

The facts on this page come from LetPub, DOAJ, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .